Vesting of Previously Granted Performance-Based Restricted Stock Units Based upon 2025 Performance.
In March 2026, (a) one-third of performance-based restricted stock units granted in 2023 vested based on actual EBITDA performance in 2023, 2024, and 2025 (cumulative) against the EBITDA target, (b) one-third of performance-based restricted stock units granted in 2024 vested based on actual EBITDA performance in 2024 and 2025 (cumulative) against the EBITDA target, and (c) one-third of performance-based restricted stock units granted in 2025 vested based on actual EBITDA performance in 2025 against the EBITDA target. The following is a summary with respect to the vesting of performance-based restricted stock units granted in each of 2023, 2024, and 2025.
Calculation of EBITDA for 2025
With respect to EBITDA for 2025, as stated above, the Compensation Committee specifically agreed to exclude from the actual EBITDA calculation any items determined by the Committee to be extraordinary and not considered in the establishment of the EBITDA target. For 2025, the Compensation Committee did not approve any exclusions.
Performance-Based Restricted Stock Units Granted in 2023
As stated above, with respect to the performance-based restricted stock units granted in 2023, one-third of such units vested in March 2026 based upon actual EBITDA performance in 2023, 2024, and 2025 cumulatively against target. The target was $749,285,000 which was based upon target EBITDA of $226,370,000 in 2023 (established in December 2022), with 10% year-over-year growth for 2024 ($249,007,000) and 2025 ($273,908,000).
EBITDA for 2025 was $320,918,000. As reported in the Company’s 2024 Proxy Statement, EBITDA for 2023 adjusted for extraordinary items was $322,594,000. As reported in the Company’s 2025 Proxy Statement, EBITDA for 2024 adjusted for extraordinary items was $358,858,000.
Adding these numbers together, this resulted in a cumulative adjusted EBITDA for 2023, 2024, and 2025 of $1,002,370, which equated to 133.78% of target EBITDA of $749,285,000, which resulted in a payment multiple of 200%.
Performance-Based Restricted Stock Units Granted in 2024
As stated above, with respect to the performance-based restricted stock units granted in 2024, one-third of such units vested in March 2026 based upon actual EBITDA performance in 2024 and 2025 cumulatively against target. The target was $748,000,000, which was based upon target EBITDA of $356,000,000 in 2024 (established in December 2023), with 10% year-over-year growth for 2025 ($392,000,000).
As stated above, adjusted EBITDA for 2025 was $320,918,000. As reported in the Company’s 2025 Proxy Statement, EBITDA for 2024 adjusted for extraordinary items was $358,858,000. Adding these numbers together, this resulted in a cumulative adjusted EBITDA for 2024 and 2025 of $679,776,000, which equated to 90.88% of target EBITDA of $748,000,000 which resulted in a payment multiple of 65.80%.
Performance-Based Restricted Stock Units Granted in 2025
As stated above, with respect to the performance-based restricted stock units granted in 2025, one-third of such units vested in March 2026 based upon actual EBITDA performance in 2025 against target. The target established in December 2024 was $380,000,000. As previously discussed, due to the macro-economic environment, the target was adjusted in May 2025 to $348,000,000. EBITDA for 2025 was $320,918,000. Against the December target, this would have resulted in a 47.1% payment multiple. Against the May target, the EBITDA performance equated to 92.22% of target, which resulted in a payment multiple of 70.82%.